Down-regulation of epidermal growth factor-induced 12-lipoxygenase expression by glucocorticoids in human epidermoid carcinoma A431 cells

Wen Chang Chang, Hsin Cho Kao, Yi Wen Liu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The effect of glucocorticoids on epidermal growth factor (EGF)-induced expression of 12-lipoxygenase in human epidermoid carcinoma A431 cells was studied. A significant suppression of the EGF-induced expression of 12-lipoxygenase was observed in cells pretreated with 1 μM dexamethasone for 2 hr. The same pretreatment for 8 hr resulted in 55 and 54% inhibition of EGF-induced 12-lipoxygenase activity and mRNA expression, respectively. Cortisol, but not sex and mineral steroids, had a similar inhibitory effect. The glucocorticoid antagonist RU486 completely blocked the inhibitory effect of dexamethasone, suggesting that the action of dexamethasone was mediated through the ligation of glucocorticoid receptors. The results indicated that pretreatment of A431 cells with glucocorticoids resulted in a down-regulation of the EGF-induced expression of 12-lipoxygenase at the mRNA and enzyme activity level, which was mediated through glucocorticoid receptor activation.

Original languageEnglish
Pages (from-to)947-952
Number of pages6
JournalBiochemical Pharmacology
Volume50
Issue number7
DOIs
Publication statusPublished - Sep 28 1995
Externally publishedYes

Fingerprint

Arachidonate 12-Lipoxygenase
Epidermal Growth Factor
Glucocorticoids
Squamous Cell Carcinoma
Down-Regulation
Dexamethasone
Glucocorticoid Receptors
Messenger RNA
Enzyme activity
Minerals
Ligation
Hydrocortisone
Chemical activation
Steroids
Enzymes

Keywords

  • 12-lipoxygenase
  • epidermal growth factor
  • glucocorticoids

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Down-regulation of epidermal growth factor-induced 12-lipoxygenase expression by glucocorticoids in human epidermoid carcinoma A431 cells. / Chang, Wen Chang; Kao, Hsin Cho; Liu, Yi Wen.

In: Biochemical Pharmacology, Vol. 50, No. 7, 28.09.1995, p. 947-952.

Research output: Contribution to journalArticle

@article{06f1b4208e044a8bbe3886d421a3b700,
title = "Down-regulation of epidermal growth factor-induced 12-lipoxygenase expression by glucocorticoids in human epidermoid carcinoma A431 cells",
abstract = "The effect of glucocorticoids on epidermal growth factor (EGF)-induced expression of 12-lipoxygenase in human epidermoid carcinoma A431 cells was studied. A significant suppression of the EGF-induced expression of 12-lipoxygenase was observed in cells pretreated with 1 μM dexamethasone for 2 hr. The same pretreatment for 8 hr resulted in 55 and 54{\%} inhibition of EGF-induced 12-lipoxygenase activity and mRNA expression, respectively. Cortisol, but not sex and mineral steroids, had a similar inhibitory effect. The glucocorticoid antagonist RU486 completely blocked the inhibitory effect of dexamethasone, suggesting that the action of dexamethasone was mediated through the ligation of glucocorticoid receptors. The results indicated that pretreatment of A431 cells with glucocorticoids resulted in a down-regulation of the EGF-induced expression of 12-lipoxygenase at the mRNA and enzyme activity level, which was mediated through glucocorticoid receptor activation.",
keywords = "12-lipoxygenase, epidermal growth factor, glucocorticoids",
author = "Chang, {Wen Chang} and Kao, {Hsin Cho} and Liu, {Yi Wen}",
year = "1995",
month = "9",
day = "28",
doi = "10.1016/0006-2952(95)00217-N",
language = "English",
volume = "50",
pages = "947--952",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Down-regulation of epidermal growth factor-induced 12-lipoxygenase expression by glucocorticoids in human epidermoid carcinoma A431 cells

AU - Chang, Wen Chang

AU - Kao, Hsin Cho

AU - Liu, Yi Wen

PY - 1995/9/28

Y1 - 1995/9/28

N2 - The effect of glucocorticoids on epidermal growth factor (EGF)-induced expression of 12-lipoxygenase in human epidermoid carcinoma A431 cells was studied. A significant suppression of the EGF-induced expression of 12-lipoxygenase was observed in cells pretreated with 1 μM dexamethasone for 2 hr. The same pretreatment for 8 hr resulted in 55 and 54% inhibition of EGF-induced 12-lipoxygenase activity and mRNA expression, respectively. Cortisol, but not sex and mineral steroids, had a similar inhibitory effect. The glucocorticoid antagonist RU486 completely blocked the inhibitory effect of dexamethasone, suggesting that the action of dexamethasone was mediated through the ligation of glucocorticoid receptors. The results indicated that pretreatment of A431 cells with glucocorticoids resulted in a down-regulation of the EGF-induced expression of 12-lipoxygenase at the mRNA and enzyme activity level, which was mediated through glucocorticoid receptor activation.

AB - The effect of glucocorticoids on epidermal growth factor (EGF)-induced expression of 12-lipoxygenase in human epidermoid carcinoma A431 cells was studied. A significant suppression of the EGF-induced expression of 12-lipoxygenase was observed in cells pretreated with 1 μM dexamethasone for 2 hr. The same pretreatment for 8 hr resulted in 55 and 54% inhibition of EGF-induced 12-lipoxygenase activity and mRNA expression, respectively. Cortisol, but not sex and mineral steroids, had a similar inhibitory effect. The glucocorticoid antagonist RU486 completely blocked the inhibitory effect of dexamethasone, suggesting that the action of dexamethasone was mediated through the ligation of glucocorticoid receptors. The results indicated that pretreatment of A431 cells with glucocorticoids resulted in a down-regulation of the EGF-induced expression of 12-lipoxygenase at the mRNA and enzyme activity level, which was mediated through glucocorticoid receptor activation.

KW - 12-lipoxygenase

KW - epidermal growth factor

KW - glucocorticoids

UR - http://www.scopus.com/inward/record.url?scp=0028858075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028858075&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(95)00217-N

DO - 10.1016/0006-2952(95)00217-N

M3 - Article

VL - 50

SP - 947

EP - 952

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 7

ER -